MPO and coronary artery disorder: Several well-established CAD biomarkers, such as inflammatory markers, including C-reactive protein (CRP), soluble CD40 ligand (sCD40L), myeloperoxidase (MPO), and B-type natriuretic peptide (BNP), are used in cardiovascular risk assessment.